Next-Generation Presbyopia-Correcting IOLs

NextGeneration PresbyopiaCorrecting IOLs
Media formats available:
Details
Presenters
  • Overview

    Drs. Cathy McCabe and Ike Ahmed discuss the types of presbyopia cataract patients that can be addressed with the latest generation of presbyopia-correcting IOLs that may have not been happy with presbyopia correction previous to this. They describe the new enhanced monofocal IOL (Eyhance), extended range of vision IOL (Vivity), and hybrid EDOF/multifocal IOL (Synergy), and how these new IOLs will expand presbyopia practices.

    This activity is supported by an unrestricted educational grant from Alcon Vision, Johnson & Johnson Vision, and Orasis Pharmaceuticals

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Describe how new presbyopia-correcting IOL designs help to maximize vision at all distances and maximize visual quality and mitigate dysphotopsia
    • Evaluate international experiences with matching patient visual needs to new presbyopia-correcting IOL innovations from doctors outside the United State
    • Accreditation

      Jointly Proviced by Evolve Medical Education and The Fundingsland Group

      ACCREDITATION STATEMENT
      This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education LLC (Evolve) and The Fundingsland Group. Evolve is accredited by the ACCME to provide continuing medical education for physicians.

      DESIGNATION STATEMENT
      Evolve designates this enduring material for a maximum of .50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • Participation Method

      In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

    • Faculty and Disclosures

      Cathleen M. McCabe, MD

      Cathleen M. McCabe, MD

      Chief Medical Officer, Eye Health America
      Medical Director, The Eye Associates
      Bradenton, FL


      Iqbal Ike K. Ahmed, MD

      Iqbal Ike K. Ahmed, MD

      Assistant Professor, University of Toronto
      Fellowship Director, Glaucoma and Anterior Segment Surgery Fellowship, University of Toronto
      Research Director, Kensington Eye Institute, University of Toronto
      Division Head, Ophthalmology, Trillium Health Partners, Mississauga, Ontario
      Medical Director, Prism Eye Institute
      Co-Medical Director, TLC Oakville
      Toronto, Canada


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

      The following faculty/staff members have the following financial relationships with commercial interests:

      Cathleen M. McCabe, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Dompe, Engage Technologies, EyePoint Pharmceuticals, Imprimis, Ivantis, Novartis, Ocular Therapeutix, Omeros, Science Based Health, Sight Sciences and Tarsus. Grant/Research Support: Alcon Vision, Allergan, Bausch + Lomb, EyePoint Pharmceuticals, Glaukos, Ivantis, Johnson & Johnson Vision, Ocular Therapeutix, and Ora. Stock/Shareholder: Engage Technologies.

      Iqbal Ike K. Ahmed, MD, had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Aequus, Aerie Pharmaceuticals, Akorn, Alcon Vision, Allergan, Aquea Health, ArcScan, Bausch Health, Beaver Health, Beaver Visitec, Camras Vision, Carl Zeiss Meditec, CorNeat Vision, Ellex, ELT Sight, ElutiMed, Equinox, Genentech, Glaukos, Gore, InjectSense, Iridex, iStar, Ivantis, Johnson & Johnson Vision, KeLoTec, LayerBio, Leica, Long Bridge Medical, MicroOptx, MST Surgical, Mynosys, New World Medical, Ocular Instruments, Ocular Therapeutix, PolyActiva, Sanoculis, Santen, Science Based Health, Sight Sciences, Smartlens, Stroma, Thea, ViaLase, and Vizzario. SpeakerHonoraria: Alcon, Allergan, Carl Zeiss Meditec, Johnson & Johnson Vision, MST Surgical, Mundipharma. Research Grants: Aerie Pharmaceuticals, Alcon Vision, Allergan, Camras, Glaukos, Johnson & Johnson Vision, New World Medical, and Santen.

      The Evolve and The Fundingsland Group staff and planners have no financial relationships with commercial interests. Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER

      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The Fundingsland Group, Alcon Vision, Johnson & Johnson Vision, and Orasis Pharmaceuticals.

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Release Date:

      Expiration Date:

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    Register

    We're glad to see you're enjoying Evolve Medical Education…
    but how about a more personalized experience?

    Register for free